# Energous Corp: financial statements, quarterly

WATT · Nasdaq · CIK 1575793 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/watt.md) · [Financials](/companies/watt/financials.md) · [Filings](/companies/watt/filings.md) · [Insiders](/companies/watt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/watt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [169](/filings/0001410578-24-001937.md) | [91.0 d](/filings/0001410578-25-000218.md) | [64.0](/filings/0001410578-25-001229.md) | [46.0](/filings/0001410578-25-001546.md) | [230](/filings/0001104659-25-111315.md) | [428 d](/filings/0001104659-26-035214.md) | [343](/filings/0001104659-26-061191.md) | [975](/filings/0001104659-26-095940.md) | [1,272](/filings/0001104659-25-111315.md) | [3,040 d](/filings/0001104659-26-035214.md) | [3,082](/filings/0001104659-26-061191.md) | [3,089](/filings/0001104659-26-095940.md) |
| Cost of revenue | $k | [48.0](/filings/0001410578-24-001937.md) | [9.0 d](/filings/0001410578-25-000218.md) | [109](/filings/0001410578-25-001229.md) | [122](/filings/0001410578-25-001546.md) | [306](/filings/0001104659-25-111315.md) | [219 d](/filings/0001104659-26-035214.md) | [250](/filings/0001104659-26-061191.md) | [637](/filings/0001104659-26-095940.md) | [814](/filings/0001104659-25-111315.md) | [1,900 d](/filings/0001104659-26-035214.md) | [1,987](/filings/0001104659-26-061191.md) | [2,995](/filings/0001104659-26-095940.md) |
| Gross profit | $k | not reported | not reported | [(45.0)](/filings/0001410578-25-001229.md) | [(76.0)](/filings/0001410578-25-001546.md) | [(76.0)](/filings/0001104659-25-111315.md) | [209 d](/filings/0001104659-26-035214.md) | [93.0](/filings/0001104659-26-061191.md) | [338](/filings/0001104659-26-095940.md) | [458](/filings/0001104659-25-111315.md) | [1,140 d](/filings/0001104659-26-035214.md) | [1,095](/filings/0001104659-26-061191.md) | [94.0](/filings/0001104659-26-095940.md) |
| Research and development | $k | [2,460](/filings/0001410578-24-001937.md) | [2,392 d](/filings/0001410578-25-000218.md) | [2,189](/filings/0001410578-25-001229.md) | [2,299](/filings/0001410578-25-001546.md) | [1,468](/filings/0001104659-25-111315.md) | [1,730 d](/filings/0001104659-26-035214.md) | [1,192](/filings/0001104659-26-061191.md) | [1,100](/filings/0001104659-26-095940.md) | [897](/filings/0001104659-25-111315.md) | [937 d](/filings/0001104659-26-035214.md) | [1,014](/filings/0001104659-26-061191.md) | [1,135](/filings/0001104659-26-095940.md) |
| Operating income | $k | [(5,081)](/filings/0001410578-24-001937.md) | [(4,596) d](/filings/0001410578-25-000218.md) | [(6,665)](/filings/0001410578-25-001229.md) | [(4,651)](/filings/0001410578-25-001546.md) | [(3,581)](/filings/0001104659-25-111315.md) | [(3,513) d](/filings/0001104659-26-035214.md) | [(3,611)](/filings/0001104659-26-061191.md) | [(2,780)](/filings/0001104659-26-095940.md) | [(2,191)](/filings/0001104659-25-111315.md) | [(1,433) d](/filings/0001104659-26-035214.md) | [(1,846)](/filings/0001104659-26-061191.md) | [(3,193)](/filings/0001104659-26-095940.md) |
| Net income | $k | [(4,114)](/filings/0001410578-24-001937.md) | [(4,605) d](/filings/0001410578-25-000218.md) | [(6,599)](/filings/0001104659-25-111315.md) | [(4,258)](/filings/0001104659-25-111315.md) | [(3,412)](/filings/0001104659-25-111315.md) | [(4,129) d](/filings/0001104659-26-035214.md) | [(3,366)](/filings/0001104659-26-095940.md) | [(2,788)](/filings/0001104659-26-095940.md) | [(2,113)](/filings/0001104659-25-111315.md) | [(1,326) d](/filings/0001104659-26-035214.md) | [(1,656)](/filings/0001104659-26-095940.md) | [(2,911)](/filings/0001104659-26-095940.md) |
| Diluted EPS | $ per share | [(0.86)](/filings/0001410578-24-001937.md) | not reported | [(1.11)](/filings/0001410578-25-001229.md) | [(0.65)](/filings/0001410578-25-001546.md) | [(14.98)](/filings/0001104659-25-111315.md) | not reported | [(3.55)](/filings/0001104659-26-061191.md) | [(2.35)](/filings/0001104659-26-095940.md) | [(1.31)](/filings/0001104659-25-111315.md) | not reported | [(0.43)](/filings/0001104659-26-061191.md) | [(0.53)](/filings/0001104659-26-095940.md) |
| Basic EPS | $ per share | [(0.86)](/filings/0001410578-24-001937.md) | not reported | [(1.11)](/filings/0001410578-25-001229.md) | [(0.65)](/filings/0001410578-25-001546.md) | [(14.98)](/filings/0001104659-25-111315.md) | not reported | [(3.55)](/filings/0001104659-26-061191.md) | [(2.35)](/filings/0001104659-26-095940.md) | [(1.31)](/filings/0001104659-25-111315.md) | not reported | [(0.43)](/filings/0001104659-26-061191.md) | [(0.53)](/filings/0001104659-26-095940.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.6](/filings/0000950170-23-063250.md) | [13.9](/filings/0001410578-25-000218.md) | [10.7](/filings/0001410578-24-000812.md) | [4.9](/filings/0001410578-24-001319.md) | [1.5](/filings/0001410578-24-001937.md) | [1.4](/filings/0001104659-26-035214.md) | [10.1](/filings/0001410578-25-001229.md) | [8.7](/filings/0001410578-25-001546.md) | [12.9](/filings/0001104659-25-111315.md) | [10.4](/filings/0001104659-26-095940.md) | [36.6](/filings/0001104659-26-061191.md) | [31.2](/filings/0001104659-26-095940.md) |
| Current assets | $m | [17.8](/filings/0000950170-23-063250.md) | [15.0](/filings/0001410578-25-000218.md) | [11.7](/filings/0001410578-24-000812.md) | [5.9](/filings/0001410578-24-001319.md) | [2.9](/filings/0001410578-24-001937.md) | [2.9](/filings/0001104659-26-035214.md) | [11.9](/filings/0001410578-25-001229.md) | [11.0](/filings/0001410578-25-001546.md) | [16.6](/filings/0001104659-25-111315.md) | [15.3](/filings/0001104659-26-095940.md) | [44.2](/filings/0001104659-26-061191.md) | [43.8](/filings/0001104659-26-095940.md) |
| Total assets | $m | [19.6](/filings/0000950170-23-063250.md) | [16.7](/filings/0001410578-25-000218.md) | [13.1](/filings/0001410578-24-000812.md) | [7.2](/filings/0001410578-24-001319.md) | [4.0](/filings/0001410578-24-001937.md) | [3.8](/filings/0001104659-26-035214.md) | [13.4](/filings/0001410578-25-001229.md) | [12.3](/filings/0001410578-25-001546.md) | [17.8](/filings/0001104659-25-111315.md) | [16.7](/filings/0001104659-26-095940.md) | [45.6](/filings/0001104659-26-061191.md) | [45.4](/filings/0001104659-26-095940.md) |
| Current liabilities | $m | [3.8](/filings/0000950170-23-063250.md) | [4.6](/filings/0001410578-25-000218.md) | [5.6](/filings/0001410578-24-000812.md) | [4.0](/filings/0001410578-24-001319.md) | [3.5](/filings/0001410578-24-001937.md) | [4.9](/filings/0001104659-26-035214.md) | [2.9](/filings/0001410578-25-001229.md) | [2.7](/filings/0001410578-25-001546.md) | [3.4](/filings/0001104659-25-111315.md) | [3.7](/filings/0001104659-26-095940.md) | [2.4](/filings/0001104659-26-061191.md) | [5.0](/filings/0001104659-26-095940.md) |
| Total liabilities | $m | [4.6](/filings/0000950170-23-063250.md) | [5.2](/filings/0001410578-25-000218.md) | [5.9](/filings/0001410578-24-000812.md) | [4.2](/filings/0001410578-24-001319.md) | [3.5](/filings/0001410578-24-001937.md) | [4.9](/filings/0001104659-26-035214.md) | [3.9](/filings/0001410578-25-001229.md) | [3.6](/filings/0001410578-25-001546.md) | [4.1](/filings/0001104659-25-111315.md) | [4.2](/filings/0001104659-26-095940.md) | [2.8](/filings/0001104659-26-061191.md) | [5.3](/filings/0001104659-26-095940.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.8](/filings/0001104659-26-035214.md) | [0.5](/filings/0001410578-25-001229.md) | [0.4](/filings/0001410578-25-001546.md) | [0.1](/filings/0001104659-25-111315.md) | [0.1](/filings/0001104659-26-095940.md) | [0.0](/filings/0001104659-26-061191.md) | [0.3](/filings/0001104659-26-095940.md) |
| Shareholders' equity | $m | [15.0](/filings/0001410578-24-001937.md) | [11.5](/filings/0001104659-26-035214.md) | [7.2](/filings/0001104659-25-111315.md) | [3.0](/filings/0001104659-25-111315.md) | [0.4](/filings/0001104659-25-111315.md) | [(1.1)](/filings/0001104659-26-095940.md) | [9.5](/filings/0001104659-26-095940.md) | [8.8](/filings/0001104659-26-095940.md) | [13.7](/filings/0001104659-25-111315.md) | [12.5](/filings/0001104659-26-095940.md) | [42.8](/filings/0001104659-26-095940.md) | [40.1](/filings/0001104659-26-095940.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(4,221) d](/filings/0001410578-24-001937.md) | [(3,333) d](/filings/0001410578-25-000218.md) | [(5,073)](/filings/0001410578-25-001229.md) | [(5,770) d](/filings/0001410578-25-001546.md) | [(4,048) d](/filings/0001104659-25-111315.md) | [(2,682) d](/filings/0001104659-26-035214.md) | [(4,668)](/filings/0001104659-26-061191.md) | [(2,878) d](/filings/0001104659-26-095940.md) | [(2,466) d](/filings/0001104659-25-111315.md) | [(2,408) d](/filings/0001104659-26-035214.md) | [(5,572)](/filings/0001104659-26-061191.md) | [(5,281) d](/filings/0001104659-26-095940.md) |
| Capital expenditure | $k | [46.0 d](/filings/0001410578-24-001937.md) | [90.0 d](/filings/0001410578-25-000218.md) | [1.0](/filings/0001410578-25-001229.md) | [57.0 d](/filings/0001410578-25-001546.md) | [65.0 d](/filings/0001104659-25-111315.md) | [0.0 d](/filings/0001104659-26-035214.md) | [21.0](/filings/0001104659-26-061191.md) | [16.0 d](/filings/0001104659-26-095940.md) | [6.0 d](/filings/0001104659-25-111315.md) | [39.0 d](/filings/0001104659-26-035214.md) | [38.0](/filings/0001104659-26-061191.md) | [235 d](/filings/0001104659-26-095940.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,880](/filings/0000950170-23-063250.md) | [4,070](/filings/0001410578-24-000812.md) | [4,562](/filings/0001410578-24-001319.md) | [4,762](/filings/0001410578-24-001937.md) | [5,961](/filings/0001410578-25-001229.md) | [6,539](/filings/0001410578-25-001546.md) | [228](/filings/0001104659-25-111315.md) | [948](/filings/0001104659-26-061191.md) | [1,188](/filings/0001104659-26-095940.md) | [1,610](/filings/0001104659-25-111315.md) | [3,882](/filings/0001104659-26-061191.md) | [5,509](/filings/0001104659-26-095940.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,527,071 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-095940.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.